Premier Fund Managers Ltd

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1673907 GUILDFORD, X0

Position in NTLA

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$100,081

New position

Shares Held

5,915

first reported quarter

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#233

of 327 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Premier Fund Managers Ltd holds $470,948 across 4 Biotechnology names. NTLA ranks #2 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCEL	Vericel Corp	4,683	$208,346
2	NTLA	Intellia Therapeutics, Inc. This page	5,915	$100,081
3	AXSM	Axsome Therapeutics, Inc.	337	$82,487
4	BEAM	Beam Therapeutics Inc.	2,332	$80,034

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$100,081	5,915	—	Shares	Sole	2026-07-22
No filing history on record for this holder in this stock.